explore -WSS

explore

author：Wikipedia 2025-10-03 00:36:20 - browse：69

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： 'Screen and refer' systems are hurting patients

WSS

Childbirth

Latest bird flu infection made farmworker sicker than earlier cases

Dexcom's push to bring CGM to type 2 diabetes patients

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Prescription digital therapeutics are key to pharma’s future

Do more moles mean more problems? Not so, says new study

explore

explore

focus

How to save PrEP access — and even expand it

Akili, maker of video game for ADHD, to be acquired for 34 million

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Lupron, used to halt puberty in children, may cause lasting health problems

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How Robert F. Kennedy Jr. distorted vaccine science

How one medical school became remarkably diverse

Biohaven protein

BioMarin wins approval for gene therapy to treat hemophilia A

Dexcom's push to bring CGM to type 2 diabetes patients

entertainment

Biohaven protein

Average age of first period drops to 11.9 years, study shows

Scientists successfully use ultrasound imaging to map brain activity

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

David Sabatini, ex

Canadians with cystic fibrosis outlive Americans by a decade

explore

knowledge

explore

explore